APA (7th ed.) Citation

O, R., JJ, J., L, M., O, T., D, C., G, C., . . . M, Z. (2020). Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors. Journal of medicinal chemistry, 63(15), 8584. https://doi.org/10.1021/acs.jmedchem.0c00988

Chicago Style (17th ed.) Citation

O, Robles, et al. "Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors." Journal of Medicinal Chemistry 63, no. 15 (2020): 8584. https://doi.org/10.1021/acs.jmedchem.0c00988.

MLA (9th ed.) Citation

O, Robles, et al. "Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors." Journal of Medicinal Chemistry, vol. 63, no. 15, 2020, p. 8584, https://doi.org/10.1021/acs.jmedchem.0c00988.